Forgiveness of BIC/FTC/TAF: In Vitro Simulations of Intermittent Poor Adherence Find Limited HIV-1 Breakthrough and High Barrier to Resistance

Conference Reports for NATAP

ID Week
Oct 21 - October 25


Forgiveness of BIC/FTC/TAF: In Vitro Simulations of Intermittent Poor Adherence Find Limited HIV-1 Breakthrough and High Barrier to Resistance

	IDWeek 2020 Oct 21-25 virtual Reported by Jules Levin Andrew Mulato, Rima Acosta*, Stephen R. Yant, Tomas Cihlar, and Kirsten White Gilead Sciences, Inc., Foster City, CA https://www.natap.org/2019/IAS/IAS_07.htm